Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110452150B discloses a novel organocatalytic route for high-purity axial chiral indole-naphthalenes. This method offers significant cost reduction in chiral catalyst manufacturing and scalable production capabilities.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Novel Pd-catalyzed multi-component route eliminates toxic CO gas, offering cost-effective production of high-purity pharmaceutical intermediates with superior scalability.
Patent CN106243033A enables low-temperature aryl nitrile production. Achieve cost reduction in pharmaceutical intermediate manufacturing with high-purity outputs.
Novel protonic acid catalysis enables cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable supply chain reliability.
Patent CN114213254B details a novel photoredox method for beta-nitroketones. Enables cost reduction in pharmaceutical intermediate manufacturing with high yields.
Patent CN111518021B reveals a novel iodide-catalyzed oxidative cyclization using styrene and DMF, offering a cost-effective, metal-free route for high-purity pharmaceutical intermediates.
Patent CN116375653A details a high enantioselective iridium-catalyzed method for chiral tetrahydroquinazoline derivatives, offering cost-effective API intermediate manufacturing solutions.
Patent CN111100085A reveals a green deep eutectic solvent method for synthesizing benzoxazine derivatives, offering cost reduction in API manufacturing and scalable production.
Patent CN112142680B details a metal-free photocatalytic route for 3-trifluoroalkylquinoxalinones, offering cost-effective and scalable manufacturing for pharmaceutical intermediates.
Patent CN112920173A details a mild, high-yield synthesis of chiral chromans with potent anticancer activity, offering reliable supply chain solutions.
Patent CN107936025B details metal-free synthesis offering high stereoselectivity and supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN105152946B enables one-step synthesis of o-Aminobenzaldehyde. High purity, mild conditions, and scalable ionic liquid catalysis for pharmaceutical supply chains.
Novel visible light iron catalysis method for 4-arylbutyronitrile. Offers 100% atom economy and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN111423351A discloses a novel chiral copper complex for asymmetric Mukaiyama Aldol reactions, offering high stereoselectivity and water tolerance for scalable API intermediate manufacturing.
Novel metal-free oxidative cyclization method for 1,2,4-triazoles. High yields, scalable process for API intermediates avoiding heavy metals.
Patent CN110452150A reveals a novel one-step synthesis for axial chiral indole-naphthalene compounds offering high purity and significant supply chain cost advantages.
Novel patent CN116354930B enables efficient tetrahydroquinoline synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel organocatalytic route for high-purity axial chiral indole-naphthalenes. Cost-effective, scalable process for chiral catalyst precursors and pharmaceutical intermediates.
Patent CN112939883B reveals a metal-free visible light method for 1,3-oxazolidines. Achieve cost reduction and scalable supply for pharmaceutical intermediates.